Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy? by Nahuel Peinetti, Marijo Bilusic, Kerry L. Burnstein

Get full text

Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations by Margaret E. Gatti-Mays, Jason M. Redman, Julie M. Collins, Marijo Bilusic

Get full text

Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report by Danielle M. Pastor, Katherine Lee-Wisdom, Andrew E. Arai, Arlene Sirajuddin, Douglas R. Rosing, Borys Korchin, James L. Gulley, Marijo Bilusic

Get full text

456 Impact of angiotensin II pathway inhibition on tumor response to anti PD(L)1 based therapy by Ravi Madan, Seth Steinberg, Jung-Min Lee, Marijo Bilusic, Fatima Karzai, Houssein Abdul Sater, Scot Niglio, Jason Redman, Charalampos Floudas, Andrea Apolo

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors by Marijo Bilusic, Christopher R. Heery, Julie M. Collins, Renee N. Donahue, Claudia Palena, Ravi A. Madan, Fatima Karzai, Jennifer L. Marté, Julius Strauss, Margaret E. Gatti-Mays, Jeffrey Schlom, James L. Gulley

Get full text

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer by Jaydira Del Rivero, Jaydira Del Rivero, Renee N. Donahue, Jennifer L. Marté, Ann W. Gramza, Marijo Bilusic, Myrna Rauckhorst, Lisa Cordes, Maria J. Merino, William L. Dahut, Jeffrey Schlom, James L. Gulley, Ravi A. Madan

Get full text

487 NC410, a fusion protein of LAIR-2 (Leukocyte Associated Immunoglobulin-like Receptor) with human IgG1 Fc, is safe & tolerable with evidence of immune modulation in subjects wit... by Ravi Madan, Siqing Fu, Marijo Bilusic, John Shin, Martin Gutierrez, Linjie Tian, Dallas Flies, Linda Liu, Solomon Langermann, Han Myint, Jahangheer Shaik, Emilia Barbu, Qinjie Zhou, Aaron Morawski, Hasan Abukharma, Ron Copeland, Megan Nelson, Stephanie Zeidan, Danielle Pastor

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) by Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Claudia Palena, Caroline Jochems, Shahrooz Rabizadeh, Patrick Soon-Shiong, Sheri McMahon, Julius Strauss, Marijo Bilusic, Fatima Karzai, Houssein Abdul Sater, Jennifer L Marté, Yo-Ting Tsai, Jason Redman, Charalampos Floudas

Get full text